Table 3: The Weekly Mean VAS Scores from the Start of Treatment (First Week) to Five Weeks Later (Sixth Week) in the Elcatonin and Placebo Groups

Group Week p Value
0 1 2 3 4 5 Time Group Time×Group
Pain at rest Elcatonin 3.00 ± 2.60 2.56 ± 2.28 1.16 ±1.14 0.73 ± 1.15 0.39 ± 0.68 0.20 ± 0.35 <0.001 0.969 0.992
Placebo 2.83 ± 2.65 2.81 ± 2.87 1.03 ± 1.31 0.70 ±0.93 0.43 ± 0.55 0.34 ± 0.59
Difference (95%CI) 0.17 (-1.73, 2.07) -0.24 (-2.14, 1.65) 0.13 (-0.77, 1.02) 0.03 (-0.72, 0.79) -0.03 (-0.48, 0.41) -0.14 (-0.50, 0.22)
Pain at motion Elcatonin 6.91 ± 1.93 4.62 ± 1.89 3.06 ± 2.05 1.83 ± 1.84 0.77 ± 0.83 0.38 ± 0.49 <0.001 0.037 0.542
Placebo 7.04 ± 2.44 5.47 ± 3.28 4.87 ± 2.76 3.03 ± 3.09 2.05 ± 2.18 1.77 ± 2.09
Difference (95%CI) -0.13 (-1.74, 1.48) -0.86 (-2.86, 1.14) -1.81 (-3.59, -0.02) -1.20 (-3.09, 0.69) -1.28 (-2.53, -0.02) -1.40 (-2.57, -0.22)

Values are listed as the mean ± standard deviation. 95% CI; 95% confidence interval